Baudax Bio BXRX
$ 0.19
0.59%
Quarterly report 2023-Q3
added 11-20-2023
Country |
USA |
IPO year |
- |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ CAPITAL |
CEO |
Dr. Geraldine A. Henwood |
Employees in the company |
24 |
Shares |
332 K |
Market Cap[1] |
$ 63 K |
EBITDA (LTM) |
$ -16.9 M |
P/E (LTM) |
- |
P/S (LTM) |
- |
EPS (LTM) |
-95.6 |
Other stocks of industry "Biotechnology"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.